Henrik Zetterberg (Former)
81 – 90 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
- Contribution to journal › Scientific review
-
Mark
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
- Contribution to journal › Article
-
Mark
Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study
- Contribution to journal › Article
-
Mark
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
- Contribution to journal › Scientific review
-
Mark
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers of glial and axonal injury in cervical spondylotic myelopathy
- Contribution to journal › Article
-
Mark
Neurofilament light as an outcome predictor after cardiac arrest : a post hoc analysis of the COMACARE trial
- Contribution to journal › Article
-
Mark
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
- Contribution to journal › Article
-
Mark
Alzheimer’s disease in primary care : new tools for improved and simplified diagnostics
- Contribution to journal › Debate/Note/Editorial
